Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation

Cytokine

Volumn 73, Issue 2, 2015, Pages 225-235

  Ryu, Jung Hwa ^a   Park, Minhwa ^a   Kim, Bo Kyung ^a   Ryu, Kyung Ha ^a   Woo, So Youn ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

B cells; CD54; CXCR2; Toll like receptors; Tonsil derived mesenchymal stromal cells

Indexed keywords

CD18 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; CHEMOKINE; MESSENGER RNA; PROTEIN BINDING; TOLL LIKE RECEPTOR 4;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; TONSIL CELL; BIOSYNTHESIS; CELL MEMBRANE; CELL PROLIFERATION; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PALATINE TONSIL;

ANTIGENS, CD18; B-LYMPHOCYTES; CELL MEMBRANE; CELL PROLIFERATION; CHEMOKINES; COCULTURE TECHNIQUES; DENDRITIC CELLS, FOLLICULAR; HUMANS; MESENCHYMAL STROMAL CELLS; PALATINE TONSIL; PHENOTYPE; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 84924935061     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.028     Document Type: Article

References (29)

1. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005, 65:3307-3318.
2. Picinich S.C., Mishra P.J., Mishra P.J., Glod J., Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 2007, 7:965-973.
3. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 2008, 30:121-127.
4. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
5. Prockop D.J. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 2009, 17:939-946.
6. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008, 105:14638-14643.
7. Cho K.A., Woo S.Y., Park Y.S., Park M.H., Ryu K.H. Macrophage inflammatory protein-2 (MIP-2)/CXCR2 blockade attenuates acute graft-versus-host disease while preserving graft-versus-leukemia activity. Biochem Biophys Res Commun 2012, 426:558-564.
8. Ryu K.H., Cho K.A., Park H.S., Kim J.Y., Woo S.Y., Jo I., et al. Tonsil-derived mesenchymal stromal cells: evaluation of biologic, immunologic and genetic factors for successful banking. Cytotherapy 2012, 14:1193-1202.
9. Cho K.A., Kim J.Y., Kim H.S., Ryu K.H., Woo S.Y. Tonsil-derived mesenchymal progenitor cells acquire a follicular dendritic cell phenotype under cytokine stimulation. Cytokine 2012, 59:211-214.
10. Romieu-Mourez R., Francois M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 2009, 182:7963-7973.
11. Hwa Cho H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006, 24:2744-2752.
12. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
13. Lei J., Wang Z., Hui D., Yu W., Zhou D., Xia W., et al. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cell Immunol 2011, 271:147-156.
14. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE 2010, 5:e10088.
15. Garin A., Meyer-Hermann M., Contie M., Figge M.T., Buatois V., Gunzer M., et al. Toll-like receptor 4 signaling by follicular dendritic cells is pivotal for germinal center onset and affinity maturation. Immunity 2010, 33:84-95.
16. Rookhuizen D.C., DeFranco A.L. Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses. Proc Natl Acad Sci USA 2014, 111:E3224-E3233.
17. Zhou Y., Guo M., Wang X., Li J., Wang Y., Ye L., et al. TLR3 activation efficiency by high or low molecular mass poly I:C. Innate Immun 2013, 19:184-192.
18. Koopman G., Parmentier H.K., Schuurman H.J., Newman W., Meijer C.J., Pals S.T. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 1991, 173:1297-1304.
19. Clark E.A., Grabstein K.H., Shu G.L. Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes. J Immunol 1992, 148:3327-3335.
20. DelaRosa O., Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm 2010, 2010:865601.
21. Raicevic G., Najar M., Stamatopoulos B., De Bruyn C., Meuleman N., Bron D., et al. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol 2011, 270:207-216.
22. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007, 204:2803-2812.
23. Lee A.Y., Eri R., Lyons A.B., Grimm M.C., Korner H. CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil?. Front Immunol 2013, 4:194.
24. Min Sung Park Y.H.K., Jung Youngmee, Kim Soo Hyun, Park Jong Chul, Yoon Dong Suk, Kim Sung-hwan, et al. In situ recruitment of human BMSCs using chemokines for articular cartilage regeneration. Cell Transplant 2014.
25. Lee Y.S., Won K.J., Park S.W., Lee H.W., Kim B., Kim J.H., et al. Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2. Cell Immunol 2012, 279:1-11.
26. Liotta F., Angeli R., Cosmi L., Fili L., Manuelli C., Frosali F., et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 2008, 26:279-289.
27. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006, 36:2566-2573.
28. Koopman G., Keehnen R.M., Lindhout E., Newman W., Shimizu Y., van Seventer G.A., et al. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 1994, 152:3760-3767.
29. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385:537-540.